A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease
Objective: The aim of this study is to compare plasma uric acid levels between pathology-confirmed and clinically misdiagnosed Parkinson’s disease patients at a single-patient level.…Comprehensive Strategy for Increasing Clinical Research Participation of Black and Hispanic Patients with Parkinsonism
Objective: To implement and test a multidimensional strategy for increasing racial and ethnic diversity in parkinsonism research. Background: Diversity in research participation is critical for…Clinical spectrum of repetitive behaviours and neuroimaging findings in adult patients with neurological Disorders: a cross-sectional Observational study
Objective: This study aimed to report the detailed clinical profile of repetitive behaviours in adult patients with neurological disorders. Background: Repetitive behaviours are observed in…Matrix in the Classroom: Augmented Reality’s Role in the Transformation of Neuroanatomy Education
Objective: This study aims to assess the impact of a novel virtual reality platform on the teaching of clinical neuroanatomy to students in health-related fields.…Clinical and Radiologic Predictors for a Longer Benefit of Cerebrospinal Fluid Decompression in Normal Pressure Hydrocephalus
Objective: To explore the clinical characteristics and predictors for longer benefit of gait after cerebrospinal fluid (CSF) decompression test in patients with normal pressure hydrocephalus…Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry
Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA
Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…Plasma MicroRNA Expression Profiling in patients with Multiple System Atrophy and Parkinson’s Disease
Objective: Our objective was to identify differentially expressed, circulating miRNAs in Multiple System Atrophy-Parkinsonian type (MSA-P) and Parkinson’s disease (PD) which could serve as diagnostic…Pain types in multiple system atrophy: results from a community-based survey
Objective: To assess the frequency of different pain types in multiple system atrophy (MSA). Background: According to a recent meta-analysis, up to 60% of individuals…Heterogeneity of multiple system atrophy with an analysis of the clinical case
Objective: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease clinically characterized by various combinations of Parkinsonism with resistance to levodopa, cerebellar, autonomic, and…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 181
- Next Page »